3rd Quarter Nsed 2024 Results. Net loss for the third quarter of 2024 was $54.4 million, compared to a net loss of $38.6 million for the third quarter of 2023. Learn more about corporate filings financial.

Auryxia® (ferric citrate) net product revenues were $35.6 million in the third quarter of 2024 as compared to $40.1 million in the third quarter of 2023. Check company quarterly results, annual earnings, financial earnings, and stocks quarterly results calendar by the moneycontrol.